Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and APPs.
Nausheen Ahmed, MD
Advertisement
Nausheen Ahmed, MD, is an associate professor of hematologic malignancies and cellular therapeutics at the University of Kansas Medical Center.
Articles by Nausheen Ahmed, MD
Advertisement
Latest Updated Articles
Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid TumorsPublished: August 10th 2025 | Updated:
Advertisement
Advertisement
